Skip to main content
Retour
Watch Compare

NextCure, Inc.

Qualité des données : 83%
NXTC
NASDAQ Manufacturing Chemicals
11,64 €
▲ 0,43 € (3,84%)
Cap. Boursière: 40,86 M
Prix
11,48 €
Cap. Boursière
40,86 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -50,09 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-209,58%
En dessous de la moyenne du secteur (-54,44%)
ROIC-138,93%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio2,97
Interest CoverageN/A

Valorisation

PE (TTM|NTM)
-0,73 | -1,84
Au-dessus de la moyenne du secteur (-1,49)
P/B Ratio1,73
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1385 pairs)
Métrique Action Médiane du Secteur
P/E -0,7 -1,5
P/B 1,7 1,6
ROE % -209,6 -54,4
Net Margin % — -41,5
Rev Growth 5Y % — 1,9
D/E — 0,3

Objectif de Cours des Analystes

3 analystes
Buy
Actuel
11,64 €
+51.8%
Objectif
17,67 €
15,00 €
18,00 €
20,00 €
Prévisions
P/E Prévisionnel -1,84
BPA Prévisionnel -6,31 €
CA Est. 0,0

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2027 -6,31 €
-9,15 € – -3,47 €
 0,0 2
FY2026 -8,21 €
-8,81 € – -7,68 €
 0,0 3

Surprises de Résultats

Derniers 4 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q42025 -2,29 € -0,81 € +64,6%
Q32025 -3,98 € -3,22 € +19,2%
Q22025 -4,62 € -11,29 € -144,6%
Q12025 -4,80 € -4,68 € +2,5%

ETFs Holding This Stock

DLHAX DLHAX
0,03% weight
DLRHX DLRHX
0,03% weight
DLHIX DLHIX
0,03% weight
BRSIX BRSIX
0,02% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -55,84 M
ROE -209,58% ROA -127,93%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -50,09 M
ROIC -138,93% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2,97
Interest Coverage N/A Asset Turnover N/A
Working Capital 21,65 M Tangible Book Value 23,65 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,73 Forward P/E -1,84
P/B Ratio 1,73 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -122,59%
Market Cap 40,86 M Enterprise Value 33,53 M
Per Share
EPS (Diluted TTM) -19,65 Revenue / Share N/A
FCF / Share -14,07 OCF / Share -13,93
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 89,69%
SBC-Adj. FCF -54,17 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — 22,38 M
Net Income -55,84 M -55,65 M -62,72 M -74,73 M -69,39 M
EPS (Diluted) -19,65 -1,99 -2,25 -2,69 -2,51
Gross Profit — — — — —
Operating Income -57,62 M -59,75 M -67,64 M -75,91 M -70,77 M
EBITDA — — — — —
R&D Expenses 44,92 M 41,49 M 47,93 M 54,20 M 50,19 M
SG&A Expenses — — — — —
D&A 2,20 M 2,90 M 3,70 M 4,10 M 4,30 M
Interest Expense — — — — —
Income Tax 0,0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 50,18 M 80,86 M 128,04 M 184,16 M 242,39 M
Total Liabilities 15,24 M 15,39 M 13,62 M 16,63 M 9,00 M
Shareholders' Equity 34,94 M 65,47 M 114,42 M 167,53 M 233,39 M
Total Debt — — — 0,0 0,0
Cash & Equivalents 25,98 M 27,73 M 13,08 M 26,63 M 12,34 M
Current Assets 43,75 M 71,81 M 112,73 M 163,98 M 227,82 M
Current Liabilities 10,57 M 9,57 M 6,88 M 9,13 M 6,61 M